KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Net Income towards Common Stockholders (2016 - 2025)

Charles River Laboratories International has reported Net Income towards Common Stockholders over the past 16 years, most recently at -$276.6 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$276.6 million for Q4 2025, down 28.21% from a year ago — trailing twelve months through Dec 2025 was -$144.3 million (down 1501.75% YoY), and the annual figure for FY2025 was -$144.3 million, down 1501.75%.
  • Net Income towards Common Stockholders for Q4 2025 was -$276.6 million at Charles River Laboratories International, down from $54.4 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for CRL hit a ceiling of $189.1 million in Q4 2022 and a floor of -$276.6 million in Q4 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was $90.0 million (2021), compared with a mean of $61.6 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 48.94% in 2022 and later tumbled 215.3% in 2024.
  • Charles River Laboratories International's Net Income towards Common Stockholders stood at $139.8 million in 2021, then soared by 35.24% to $189.1 million in 2022, then dropped by 1.07% to $187.1 million in 2023, then tumbled by 215.3% to -$215.7 million in 2024, then dropped by 28.21% to -$276.6 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$276.6 million (Q4 2025), $54.4 million (Q3 2025), and $52.3 million (Q2 2025) per Business Quant data.